Drug Shortage Report for ERFA-AMIKACIN
Report ID | 139653 |
Drug Identification Number | 02489147 |
Brand name | ERFA-AMIKACIN |
Common or Proper name | ERFA-AMIKACIN |
Company Name | SEARCHLIGHT PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | AMIKACIN |
Strength(s) | 250MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
Packaging size | 2ML |
ATC code | J01GB |
ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-06-01 |
Actual start date | 2021-05-19 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2021-12-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1600 RUE NOTRE DAME OUEST, SUITE 312 MONTREAL, QUEBEC CANADA H3J 1M1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-05-19 | English | Compare |
v2 | 2021-05-19 | French | Compare |
v3 | 2021-05-20 | English | Compare |
v4 | 2021-12-08 | English | Compare |
v5 | 2021-12-08 | English | Compare |
v6 | 2021-12-08 | French | Compare |
Showing 1 to 6 of 6